Alternate splicing of the p53 inhibitor HDMX offers a superior prognostic biomarker than p53 mutation in human cancer.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Helge Taubert Pancras C.W. Hogendoorn Marieke L Kuijjer |
| Publication date | June 14, 2012 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |